Only WT USP30 significantly inhibited tumor‐sphere formation in MDA‐MB‐231 cells, while both the nuclear‐localization‐deficient NLS2m and catalytic inactive C77S mutants lost this capacity (Figure 3H and Figure S3G). The gene discussed is USP30; the disease is neoplasm.